179 results match your criteria: "Royal College of Pathologists of Australasia[Affiliation]"

Dedicated warfarin care programme results in superior warfarin control in Queensland, Australia.

Int J Clin Pract

March 2018

Menzies Health Institute and Quality Use of Medicines Network, Griffith University, Queensland, Australia.

Background: Warfarin is used to prevent stroke in patients with atrial fibrillation (AF). Ongoing monitoring of International normalised ratio (INR) and time in therapeutic range (TTR) commonly used to assess the quality of warfarin management are required. Anticoagulant clinics have demonstrated improved TTRs, particularly in countries with poorer control in primary care settings.

View Article and Find Full Text PDF

The Royal College of Pathologists of Australasia Quality Assurance Program: Immunohistochemistry Breast Marker Audit Overview 2005-2015.

Appl Immunohistochem Mol Morphol

January 2019

*Department of Anatomical Pathology, The Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP), Sydney, NSW †Department of Histopathology, Monash Health, Monash Medical Centre, Melbourne, Vic. ‡Department of histopathology, Genomics for Life, Qld, Australia.

The Royal College of Pathologists of Australasia Quality Assurance Program (RCPAQAP) Anatomical Pathology provides a comprehensive External Quality Assurance (EQA) exercise to review the reporting of immunohistochemistry (IHC) and in-situ hybridization (ISH) breast markers through an audit of clinical results. The aim of this exercise was to provide information regarding the quality of breast marker testing within clinical laboratories from 2005 to 2015. This comprehensive audit included estrogen, progesterone, and HER2 marker reporting.

View Article and Find Full Text PDF

Aims: To review the Royal College of Pathologists of Australasia (RCPA) Quality Assurance Program Dermatopathology module from 2005 to 2016 to assess diagnostic performance, changes over time, and areas of diagnostic difficulty.

Methods: The computerized records of the RCPA Dermatopathology subspecialist module were reviewed. Cases were categorized into groups including nonneoplastic disorders, neoplasms, and cases with multiple diagnoses.

View Article and Find Full Text PDF

Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders.

Methods Mol Biol

May 2018

Haematology Department, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW Health Pathology, Westmead, NSW, 2145, Australia.

Hemostasis is a complex and tightly regulated process whereby the body attempts to maintain a homeostatic balance to permit normal blood flow, without bleeding or thrombosis. When this balance is disrupted, due to trauma or underlying congenital bleeding or thrombotic disorders, clinical intervention may be required. To assist clinicians in diagnosing and managing affected patients, hemostasis laboratories offer an arsenal of tests, both routine (screening) and more specialized (diagnostic).

View Article and Find Full Text PDF

Introduction: Diabetes is a major health problem for Australia's Aboriginal and Torres Strait Islander peoples. Point-of-care testing for haemoglobin A1c (HbA1c) has been the cornerstone of a long-standing program (QAAMS) to manage glycaemic control in Indigenous people with diabetes and recently, to diagnose diabetes.

Methods: The QAAMS quality management framework includes monthly testing of quality control (QC) and external quality assurance (EQA) samples.

View Article and Find Full Text PDF

Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Int J Gynecol Pathol

May 2018

Department of Pathology, Belfast Health and Social Care Trust, Belfast and Chair of the ICCR Cervical Carcinoma Panel (W.G.M.) Department of Histopathology, Addenbrookes Hospital, Cambridge and ICCR Steering Group Representative (B.R.) Department of Cellular Pathology, Birmingham Women's Hospital, Birmingham and ICCR Steering Group Representative (L.H.), UK Royal College of Pathologists of Australasia, Sydney, NSW (M.J.J.) Department of Histopathology, King Edward Memorial Hospital, Perth, WA (C.J.R.S.), Australia Department of Pathology, Mexican Oncology Hospital, IMSS, Mexico City, Mexico (I.A.C.) Department of Pathology and Laboratory Medicine, University of Calgary, AB (M.A.D.) Gynecologic Oncology Service, Centre Hospitalier Universitaire de Québec, L'Hôtel-Dieu de Québec, Laval University, QC (M.P.), Canada Division of Gynecologic, Breast & Perinatal Pathology,University Hospital Leipzig, Germany (L.C.H.) Department of Pathology, Yale University School of Medicine, New Haven, CT (P.H.) ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain (J.O.) Department of Pathology, University of Massachusetts Medical Center-Baystate Health, Springfield, MA (C.N.O.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY (K.J.P.) Department of Pathology, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Ghana (E.K.W.).

A comprehensive pathologic report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but the content of these is variable. The International Collaboration on Cancer Reporting is an alliance formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, for the purpose of developing standardized, evidence-based reporting data sets for each cancer site.

View Article and Find Full Text PDF

External Quality Assessment beyond the analytical phase: an Australian perspective.

Biochem Med (Zagreb)

February 2017

Centre for Health Systems and Safety Research, Macquarie University, North Ryde, Australia.

External Quality Assessment (EQA) is the verification, on a recurring basis, that laboratory results conform to expectations for the quality required for patient care. It is now widely recognised that both the pre- and post-laboratory phase of testing, termed the diagnostic phases, are a significant source of laboratory errors. These errors have a direct impact on both the effectiveness of the laboratory and patient safety.

View Article and Find Full Text PDF

This is the result of a Survey of various aspects of quality, cost and speed in a large sample of diagnostic laboratories in the Asia Pacific region. It is the first of its type to be published and represents a snapshot of the current performance in a large number of diagnostic laboratories in a broad range of countries in the Asia Pacific region. This demonstrates that there are common issues facing all the laboratories surveyed but also common solutions using a Quality Systems approach which involves Accreditation, Customer responsiveness, greater use of IT, automation and Lean principles.

View Article and Find Full Text PDF

Ebola Preparedness: Diagnosis Improvement Using Rapid Approaches for Proficiency Testing.

J Clin Microbiol

March 2017

Serology and Virology Division, South Eastern Area Laboratory Services Microbiology, Prince of Wales Hospital, NSW Health Pathology, Sydney, NSW, Australia

The unprecedented 2015 Ebolavirus (EBOV) outbreak in West Africa was declared a public health emergency, making diagnosis and quality of testing a global issue. The accuracy of laboratory diagnostic capacity for EBOV was assessed in 2014 to 2016 using a proficiency testing (PT) strategy developed by the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) in Biosecurity. Following a literature search, EBOV-specific gene targets were ranked according to the frequency of their use in published methods.

View Article and Find Full Text PDF

Aims: The International Collaboration on Cancer Reporting (ICCR) is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom, the College of American Pathologists, the Canadian Association of Pathologists-Association Canadienne des Pathologists in association with the Canadian Partnership Against Cancer, and the European Society of Pathology. Its goal is to produce standardized, internationally agreed, evidence-based datasets for use throughout the world.

Methods And Results: This article describes the development of a cancer dataset by the multidisciplinary ICCR expert panel for the reporting of thymic epithelial tumours.

View Article and Find Full Text PDF

Background: Warfarin is a leading anticoagulant in the management of atrial fibrillation (AF) and deep vein thrombosis (DVT). Drug interactions influence the safety of warfarin use and while extensive literature exists regarding the effect on warfarin control and bleeding incidence with many medicines, there is little evidence on the influence of complementary medicines. The aim of this study was to assess the influence of fish and krill oil supplementation on warfarin control and bleeding incidence in AF and DVT patients.

View Article and Find Full Text PDF

Objective Little research exists regarding the prevalence of patient non-adherence with completing pathology requests for chronic disease monitoring. The aims of the present study were to determine the extent to which this exists in diabetic patients and to identify possible reasons contributing to this behaviour. Methods Patients diagnosed with type 2 diabetes mellitus were recruited from three general practices with different demographics.

View Article and Find Full Text PDF

Kings to Cowards: One-Punch Assaults.

J Law Med Ethics

June 2016

Jason Schreiber, FFCFM, MFFLM, DipFLM, is a Forensic Physician at the Clinical Forensic Department of the Victorian Institute of Forensic Medicine. Angela Williams, MBBS, GradDipForensMed, MForensMed, GradDipLaw, FFFLM (UK), GAICD, MBA, FFCFM (RCPA), is a Senior Forensic Physician in the Clinical Forensic Medicine Department of the Victorian Institute of Forensic Medicine. She is an Adjunct Senior Lecturer in the Department of Forensic Medicine at Monash University, Victoria, Australia. Dr Williams is a Founding Fellow of the Faculty of Clinical Forensic Medicine of the Royal College of Pathologists of Australasia and a Fellow of the Faculty of Forensic and Legal Medicine of the Royal College of Physicians, United Kingdom. David Ranson, B. Med. Sci., B.M., B.S., LLB., FRCPath., FRCPA., FACLM., FFFLM., FFCFM., DMJ (Path)., is a is Deputy Director of the Victorian Institute of Forensic Medicine in charge of the Forensic Service Division which covers a range of Forensic Laboratory Sciences, Clinical Forensic Medicine and Forensic Pathology.

Methodology: Literature Review and medico-legal commentary.

Results: Fatal one-punch assaults have been reported extensively in the media. This article provides a commentary on recent policy developments and legislative amendments in Australia regarding so called 'one-punch' assaults.

View Article and Find Full Text PDF

We examined whether introduction of a structured macroscopic reporting template for rectal tumour resection specimens improved the completeness and efficiency in collecting key macroscopic data elements. Fifty free text (narrative) macroscopic reports retrieved from 2012 to 2014 were compared with 50 structured macroscopic reports from 2013 to 2015, all of which were generated at John Hunter Hospital, Newcastle, NSW. The six standard macroscopic data elements examined in this study were reported in all 50 anatomical pathology reports using a structured macroscopic reporting dictation template.

View Article and Find Full Text PDF

Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Arch Pathol Lab Med

October 2016

From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley).

Context: -The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists-Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world.

Objective: -To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum.

View Article and Find Full Text PDF

Aim: The purpose of this survey was to determine the cut-offs being used by Australian laboratories using their instrument's Haemolysis Index (HI), whether these cut-offs vary, and at what level of haemolysis (or haemolysis index) did laboratories stop reporting one or more analytes. This was done in response to the large numbers of haemolysed samples reported in the RCPAQAP Key Incident Monitoring and Management System External Quality Assurance program (KIMMS EQA) and lack of information in the literature at the time regarding what to do once a haemolysed sample was identified. As it was known from discussions with laboratory personnel that different instruments reported their HI differently, we asked for the results to be provided in g/L free haemoglobin.

View Article and Find Full Text PDF

Review and Recommendations for the Component Tests in the Liver Function Test Profile.

Indian J Clin Biochem

March 2016

Faculty of Health Sciences and Medicine, Bond University, Robina, Australia.

Pathology laboratories group some tests that they perform on their high throughput biochemistry analysers into profiles of tests that are associated with different organs (e.g. liver function tests-LFT).

View Article and Find Full Text PDF

Background: Diagnostic cytopathology is an essential part of clinical decision-making. However, due to a combination of factors including curriculum reform and shortage of pathologists to teach introductory cytopathology, this area of pathology receives little or no formal attention in most medical school curricula. We have previously described the successful use of efficient and effective digital learning resources, including whole slide images (WSI) and virtual microscopy adaptive tutorials (VMATs), to teach cytopathology to pathology specialist trainees - a group that had prior exposure to cytopathology in their day to day practice.

View Article and Find Full Text PDF

Background: The constant growth in the body of knowledge in medicine requires pathologists and pathology trainees to engage in continuing education. Providing them with equitable access to efficient and effective forms of education in pathology (especially in remote and rural settings) is important, but challenging.

Methods: We developed three pilot cytopathology virtual microscopy adaptive tutorials (VMATs) to explore a novel adaptive E-learning platform (AeLP) which can incorporate whole slide images for pathology education.

View Article and Find Full Text PDF

Review of the cultural safety of a national Indigenous point-of-care testing program for diabetes management.

Aust J Prim Health

October 2017

Flinders University International Centre for Point-of-Care Testing, Sturt Campus, West Wing, Level 3, Flinders University, Bedford Park, SA 5042, Australia.

In Australia, Aboriginal and Torres Strait Islander people have approximately three-fold higher rates of diabetes than non-Indigenous Australians. Point-of-care testing, where pathology tests are conducted close to the patient, with results available during the patient consultation, can potentially deliver several benefits for both the Indigenous client and the health professional team involved in their care. Currently, point-of-care testing for diabetes management is being conducted in over 180 Aboriginal and Torres Strait Islander Medical Services as part of a national program called Quality Assurance for Aboriginal and Torres Strait Islander Medical Services (QAAMS).

View Article and Find Full Text PDF

Key quality parameters in diagnostic pathology include timeliness, accuracy, completeness, conformance with current agreed standards, consistency and clarity in communication. In this review, we argue that with worldwide developments in eHealth and big data, generally, there are two further, often overlooked, parameters if our reports are to be fit for purpose. Firstly, population-level studies have clearly demonstrated the value of providing timely structured reporting data in standardised electronic format as part of system-wide quality improvement programmes.

View Article and Find Full Text PDF

Background: The Royal College of Pathologists of Australasia (RCPA) Porphyrin Quality Assurance Program assesses the measurement of urine, faecal, plasma and whole blood porphyrins and their components plus urinary porphobilinogen and delta aminolaevulinic acid and has laboratories enrolled from around the world. It was observed that there was a wide scatter in results submitted to some subsections of the program.

Methods: A detailed questionnaire covering the analytical techniques used in the diagnosis of porphyria was sent to all laboratories enrolled in the RCPA Porphyrin Quality Assurance Program.

View Article and Find Full Text PDF